Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Gowen

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annual Review of Immunology|January 10, 2013
Regulation of ligands for the NKG2D activating receptorDavid H Raulet, Stephan Gasser, Benjamin G Gowen, et al.
Nature Reviews. Drug Discovery|December 24, 2016
Cornerstones of CRISPR-Cas in drug discovery and therapyChristof Fellmann, Benjamin G Gowen, Pei-Chun Lin, et al.
Advances in Immunology|February 11, 2014
Recognition of tumors by the innate immune system and natural killer cellsAssaf Marcus, Benjamin G Gowen, Thornton W Thompson, et al.
Science (New York, N.Y.)|March 7, 2015
Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejectionWeiwen Deng, Benjamin G Gowen, Li Zhang, et al.
Cell Reports|August 7, 2020
ATF4 Regulates MYB to Increase γ-Globin in Response to Loss of β-GlobinMandy Y Boontanrart, Markus S Schröder, Gautier M Stehli, et al.
Plos One|February 24, 2025
Systematic identification and characterization of high efficiency Cas9 guide RNAs for therapeutic targeting of ADARBenjamin G Gowen, Kory Melton, Weng In Leong, et al.
Nature|March 8, 2020
Author Correction: SLC19A1 transports immunoreactive cyclic dinucleotidesRutger D Luteijn, Shivam A Zaver, Benjamin G Gowen, et al.
Nature|September 13, 2019
SLC19A1 transports immunoreactive cyclic dinucleotidesRutger D Luteijn, Shivam A Zaver, Benjamin G Gowen, et al.
Elife|November 14, 2015
A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cellsBenjamin G Gowen, Bryan Chim, Caleb D Marceau, et al.
Molecular Cell|July 1, 2020
The Histone Chaperone FACT Induces Cas9 Multi-turnover Behavior and Modifies Genome Manipulation in Human CellsAlan S Wang, Leo C Chen, R Alex Wu, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annual Review of Immunology|January 10, 2013
Regulation of ligands for the NKG2D activating receptorDavid H Raulet, Stephan Gasser, Benjamin G Gowen, et al.
Nature Reviews. Drug Discovery|December 24, 2016
Cornerstones of CRISPR-Cas in drug discovery and therapyChristof Fellmann, Benjamin G Gowen, Pei-Chun Lin, et al.
Advances in Immunology|February 11, 2014
Recognition of tumors by the innate immune system and natural killer cellsAssaf Marcus, Benjamin G Gowen, Thornton W Thompson, et al.
Science (New York, N.Y.)|March 7, 2015
Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejectionWeiwen Deng, Benjamin G Gowen, Li Zhang, et al.
Cell Reports|August 7, 2020
ATF4 Regulates MYB to Increase γ-Globin in Response to Loss of β-GlobinMandy Y Boontanrart, Markus S Schröder, Gautier M Stehli, et al.
Plos One|February 24, 2025
Systematic identification and characterization of high efficiency Cas9 guide RNAs for therapeutic targeting of ADARBenjamin G Gowen, Kory Melton, Weng In Leong, et al.
Nature|March 8, 2020
Author Correction: SLC19A1 transports immunoreactive cyclic dinucleotidesRutger D Luteijn, Shivam A Zaver, Benjamin G Gowen, et al.
Nature|September 13, 2019
SLC19A1 transports immunoreactive cyclic dinucleotidesRutger D Luteijn, Shivam A Zaver, Benjamin G Gowen, et al.
Elife|November 14, 2015
A forward genetic screen reveals novel independent regulators of ULBP1, an activating ligand for natural killer cellsBenjamin G Gowen, Bryan Chim, Caleb D Marceau, et al.
Molecular Cell|July 1, 2020
The Histone Chaperone FACT Induces Cas9 Multi-turnover Behavior and Modifies Genome Manipulation in Human CellsAlan S Wang, Leo C Chen, R Alex Wu, et al.
Pageof 2